Clinical Trials
15
Active:0
Completed:8
Trial Phases
5 Phases
Phase 1:1
Phase 2:2
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (46.2%)Phase 4
3 (23.1%)Phase 2
2 (15.4%)Phase 1
1 (7.7%)Phase 3
1 (7.7%)Immediate vs. Elective Endoscopic Removal of Large CBD Stones in High-Risk Elderly Patients
Not Applicable
Completed
- Conditions
- CholedocholithiasisJaundice, Obstructive
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- National Liver Institute, Egypt
- Target Recruit Count
- 400
- Registration Number
- NCT06948279
- Locations
- 🇪🇬
National Liver Institute, Menoufia University, Egypt., Shebeen El-Kom, Menoufiya, Egypt
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
Not Applicable
Recruiting
- Conditions
- Granulocyte Colony-stimulating FactorBiliary Atresia
- Interventions
- Drug: Granulocyte Colony-Stimulating Factor
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- National Liver Institute, Egypt
- Target Recruit Count
- 40
- Registration Number
- NCT06708572
- Locations
- 🇪🇬
National Liver Institute, Cairo, Menofia Governorate, Egypt
Proton Pump Inhibitors in Cirrhotic Patients
Completed
- Conditions
- Proton Pump Inhibitor Adverse ReactionLiver Cirrhosis
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- National Liver Institute, Egypt
- Target Recruit Count
- 1000
- Registration Number
- NCT06384443
- Locations
- 🇪🇬
National Liver institute - Menoufia University, Shibīn Al Kawm, Menoufia, Egypt
Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia
Phase 3
Completed
- Conditions
- Neonatal Jaundice
- Interventions
- Drug: Oral zinc sulfate and standard phototherapy
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- National Liver Institute, Egypt
- Target Recruit Count
- 192
- Registration Number
- NCT06227624
- Locations
- 🇪🇬
National Liver Institute, Shibīn Al Kawm, Menoufia, Egypt
Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
Phase 4
- Conditions
- Helicobacter Pylori
- Interventions
- Drug: Naïve patients - ACO therapyDrug: Naïve patients - LNDL therapyDrug: Naïve patients - MNDL therapyDrug: Treatment-experienced patients- LNDL therapyDrug: Treatment-experienced patients- MNDL therapy
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- National Liver Institute, Egypt
- Target Recruit Count
- 500
- Registration Number
- NCT05184491
- Locations
- 🇪🇬
National Liver institute - Menoufia University, Shibīn Al Kawm, Menoufia, Egypt
- Prev
- 1
- 2
- 3
- Next
News
No news found